Virtual Event Coverage

The LD 500

September 1-4, 2020 - Virtual Event
LD Micro - The LD 500

The LD 500 is the most ambitious project in LD Micro's 14-year history of leading the micro-cap space as an independent resource. Investors will enjoy updates from hundreds of companies that represent a wide variety of industries. Featuring some of the most prominent companies in the micro-cap world, the LD 500 also incorporates interviews and keynotes with small-cap royalty.

For more information visit:
The LD 500 Conference Portal LD Micro Website

Presenting Companies: A - I J - R S - Z

Acer Therapeutics Inc. (NASDAQ: ACER)

Acer Therapeutics Inc. (NASDAQ: ACER) is a pharmaceutical company focused on the acquisition, development and commercialization of treatments for rare and life-threatening diseases with significant unmet medical needs. Acer's pipeline includes four clinical-stage candidates. Acer's product candidates present a relatively de-risked profile, having one or more of a favorable safety profile, clinical proof-of-concept data, mechanistic differentiation and/or accelerated paths for development through specific programs and procedures established by the FDA. For more information, visit the company's website at

Acme United Corporation (NYSE American: ACU)

Acme United Corporation (NYSE American: ACU) is a leading worldwide supplier of innovative cutting, measuring, first aid and sharpening products to the school, home, office, hardware, sporting goods and industrial markets with operations in the United States, Canada, Europe (located in Germany) and Asia (located in Hong Kong and China). Acme United strives to be known for quality and innovation in all categories in which it participates and to enter new categories with innovation that surpasses the competition. For more information, visit the company's website at

ADDvantage Technologies Group Inc. (NASDAQ: AEY)

ADDvantage Technologies Group Inc. (NASDAQ: AEY) is a communications infrastructure services and equipment provider operating a diversified group of companies through its wireless infrastructure services and telecommunications segments. ADDvantage operates through its subsidiaries, Fulton Technologies, Nave Communications and Triton Datacom. Fulton Technologies provides turn-key wireless infrastructure services including the installation, modification and upgrading of equipment on communication towers and small cell sites for wireless carriers, national integrators, tower owners and major equipment manufacturers. Through its telecommunications segment, Nave Communications and Triton Datacom sell equipment and hardware used to acquire, distribute and protect the communications signals carried on fiber optic, coaxial cable and wireless distribution systems. The telecommunications segment also offers repair services focused on telecommunication equipment and recycling surplus and related obsolete telecommunications equipment. For more information, visit the company's website at

Adial Pharmaceuticals Inc. (NASDAQ: ADIL)

Adial Pharmaceuticals Inc. (NASDAQ: ADIL) is a clinical-stage biopharmaceutical company focusing on the development of treatments for addictions. The company's lead investigational new drug product, AD04, is a genetically targeted, serotonin-3 receptor antagonist therapeutic agent for the treatment of alcohol use disorder (AUD). AD04 is being investigated in a landmark ONWARD(TM) pivotal Phase 3 clinical trial. A Phase 2b clinical trial of AD04 for the treatment of AUD showed promising results in reducing frequency and quantity of drinking. AD04 is also believed to have the potential to treat other addictive disorders such as opioid use disorder, gambling and obesity. For more information, visit the company's website at

Advaxis Inc. (NASDAQ: ADXS)

Advaxis Inc. (NASDAQ: ADXS) is a clinical-stage biotechnology company focused on the development and commercialization of proprietary Listeria monocytogenes (Lm) antigen delivery products. These immunotherapies are based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant fusion proteins. These Lm-based strains are believed to be a significant advancement in immunotherapy, as they integrate multiple functions into a single immunotherapy and are designed to access and direct antigen presenting cells to stimulate anti-tumor T cell immunity, activate the immune system with the equivalent of multiple adjuvants and simultaneously reduce tumor protection in the tumor microenvironment to enable T cells to eliminate tumors. For more information, visit the company's website at

Aehr Test Systems (NASDAQ: AEHR)

Aehr Test Systems (NASDAQ: AEHR) is a worldwide provider of test systems for burning-in and testing logic, optical and memory integrated circuits. The company has installed over 2,500 systems worldwide. An increasing need for quality and reliability of the automotive and mobility integrated circuit markets is driving additional test requirements, incremental capacity needs and new opportunities for Aehr Test products in package, wafer level and singulated die/module level tests. For more information, visit the company's website at

Alkido Pharma Inc. (NASDAQ: AIKI)

Alkido Pharma Inc. (NASDAQ: AIKI) is a biotechnology company with a diverse portfolio of small-molecule anti-cancer therapeutics. Aikido's platform consists of patented technology from leading universities and researchers. The company is currently in the process of developing an innovative therapeutic drug platform through strong partnerships with world renowned educational institutions, including The University of Texas at Austin and Wake Forest University. For more information, visit the company's website at

AIM ImmunoTech Inc. (NYSE American: AIM)

AIM ImmunoTech Inc. (NYSE American: AIM) is an immuno-pharma company focused on the research and development of new therapeutics to treat seriously debilitating immune disorders, viral diseases and multiple types of cancers. AIM's flagship products include Argentina-approved drug rintatolimod (trade names Ampligen(R) or Rintamod(R)) and FDA-approved drug Alferon N Injection(R). Uses will require additional clinical trials to confirm the safety and effectiveness data necessary to support regulatory approval and additional funding. Rintatolimod is a double-stranded RNA candidate being developed for globally important debilitating diseases and disorders of the immune system. For more information, visit the company's website at

Air Industries Group (NYSE American: AIRI)

Air Industries Group (NYSE American: AIRI) supplies flight critical and other sophisticated parts and assemblies to the world's premier aerospace and ground power companies. Air Industries products support the premier aircraft in the armed forces, including the newest fighter: the Lockheed F-35 Joint Strike Fighter (all variants). As an aerospace and defense company, Air Industries manufactures and designs structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls, throttle quadrants, jet engines and other components. The company also provides sheet metal fabrication of aerostructures, tube bending and welding services. It reports into two segments: complex machining and turbine engine components. For more information, visit the company's website at

Akerna Corp. (NASDAQ: KERN)

Akerna Corp. (NASDAQ: KERN) is a global regulatory compliance technology company based in Denver, Colorado. The cornerstones of Akerna's service are the MJ Platform(R) and Leaf Data Systems(R), which are highly versatile platforms that provide clients and government entities with a central data management system for tracking regulated cannabis products through the complete supply chain from seed to sale. Since its establishment in 2010, Akerna has tracked more than $18 billion in cannabis sales across 14 countries and has served clients in 29 states across the U.S. As part of its business strategy, Akerna intends to grow through targeted, strategic acquisitions that are complementary to its current business and organically by accelerating its product development efforts. For more information, visit the company's website at

Algernon Pharmaceuticals Inc. (CSE: AGN) (OTCQB: AGNPF)

Algernon Pharmaceuticals Inc. (CSE: AGN) (OTCQB: AGNPF) is a clinical-stage pharmaceutical development company that investigates safe, already approved drugs for new disease applications. Algernon is a drug re-purposing company focused on moving these drugs efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off-label prescription writing. Algernon has filed new intellectual property rights globally for NP-120 (Ifenprodil) for the treatment of respiratory diseases such as COVID-19 and is working to develop a proprietary injectable and slow release formulation. For more information, visit the company's website at

Alimera Sciences Inc. (NASDAQ: ALIM)

Alimera Sciences Inc. (NASDAQ: ALIM) is a global pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals for the treatment of retinal diseases. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and affect millions of people globally. Alimera recently initiated the company's Phase 4 NEW DAY clinical trial, a randomized, controlled, multi-center study designed to generate prospective data for ILUVIEN(R) (fluocinolone acetonide intravitreal implant) 0.19 mg as a baseline therapy in patients diagnosed with diabetic macular edema (DME). For more information, visit the company's website at


Allot Ltd. (NASDAQ: ALLT) (TASE: ALLT) is a leading provider of innovative network intelligence and security solutions that empower communications service providers and enterprises worldwide, bringing enhanced value to customers. Allot's solutions are deployed globally for network and application analytics, traffic control and shaping, network-based security services and more. With more than 20 years of proven success, Allot's solutions turn network, application, usage and security data into actionable intelligence, making customers' networks smarter and their users more secure. Allot's multi-service platforms are deployed by over 500 mobile, fixed and cloud service providers and over 1,000 enterprises. Allot's industry-leading, network-based security as a service solution has achieved over 50 percent penetration with some service providers and is already used by over 23 million subscribers in Europe. For more information, visit the company's website at

Alpine 4 Technologies Ltd. (OTCQB: ALPP)

Alpine 4 Technologies Ltd. (OTCQB: ALPP) is a publicly traded, multi-faceted conglomerate with divergent products and business-related services in software, automotive technologies, electronics manufacturing and energy services and fabrication technologies. Alpine 4's highly diversified acquisition model is industry agnostic and is based around the company's driver, stabilizer, facilitator business model. The company's motto of "SIDE" (Synergistic Innovation Drives Excellence) provides its subsidiaries with access to greater talent, resources and skillsets. Subsidiaries prosper through strong onsite leadership while working synergistically with other Alpine 4 holdings. This unique perspective has culminated in the development of the company's blockchain-enabled enterprise business operating system called SPECTRUMebos. For more information, visit the company's website at

American Shared Hospital Services (NYSE American: AMS)

American Shared Hospital Services (NYSE American: AMS) is a publicly traded health care company with more than 30 years of leasing state-of-the-art medical equipment to hospitals and medical centers in the U.S. and abroad. Through its business operations, the company provides the following: gamma knife stereotactic radiosurgery, which is an alternative to conventional brain surgery and/or radiation therapy; image guided radiation therapy, which captures cone beam imaging, fluoroscopic and x-ray images, identifying exact sizes, locations and coordinates of tumors; and proton beam radiation therapy, which treats prostate, brain, spine, head and neck, lung, breast, gastrointestinal tract and pediatric tumors. American Shared Hospital Services advances the quality of health care by bringing breakthrough technologies to health care institutions, helping them best serve their communities. For more information, visit the company's website at

AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF)

AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) is an artificial intelligence, machine-learning company that transforms data into knowledge. AnalytixInsight's financial analytics platform,, algorithmically analyzes market price data and regulatory filings to create insightful, actionable narratives and research on approximately 50,000 global companies and North American ETFs, providing high-quality financial research and content for investors, information providers, finance portals and media. AnalytixInsight also designs and implements workforce optimization solutions for large global enterprises. AnalytixInsight holds a 49% interest in MarketWall, a developer of fintech solutions for financial institutions. For more information, visit the company's website at

Annovis Bio Inc. (NYSE American: ANVS)

Annovis Bio Inc. (NYSE American: ANVS) is a clinical-stage drug platform company addressing neurodegeneration such as Alzheimer's disease, Parkinson's disease and Alzheimer's in Down Syndrome. With an aging population, neurodegenerative diseases have become one of the world's largest unmet medical needs. Nerve cell death is the underlying cause of all neurodegenerative disease in both slow chronic and fast acute injuries to the brain. Annovis is developing novel treatments that are expected to improve memory loss and dementia associated with Alzheimer's disease and Alzheimer's in Down Syndrome, as well as body and brain function in Parkinson's disease. Annovis has an ongoing Phase 2a study in Alzheimer's disease patients and plans to begin a second Phase 2a study in Parkinson's disease and Alzheimer's disease patients. For more information, visit the company's website at

Antibe Therapeutics Inc. (TSX.V: ATE) (OTCQB: ATBPF) ATE) (OTCQB: ATBPF)

Antibe Therapeutics Inc. (TSX.V: ATE) (OTCQB: ATBPF) is a biotechnology company exploiting groundbreaking advances in inflammation science. Antibe targets blockbuster opportunities to develop safer, non-addictive medicines for pain and inflammation. Antibe's technology involves the linking of a proprietary hydrogen sulfide-releasing molecule to an existing drug to produce an improved medicine. Antibe's lead drug, ATB-346, targets the global need for a safer, non-addictive drug for chronic pain and inflammation. ATB-352, the second drug in Antibe's pipeline, targets the urgent global need for a non-addictive analgesic for treating post-surgical pain, while ATB-340 is a GI-safe derivative of aspirin. Citagenix Inc., an Antibe subsidiary, is a market leader and worldwide distributor of regenerative medicine products for the dental marketplace. For more information, visit the company's website at

Apollo Endosurgery Inc. (NASDAQ: APEN)

Apollo Endosurgery Inc. (NASDAQ: APEN) is a global medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal complications to the treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total health care costs. Apollo's products are offered in over 75 countries today and include the OverStitch(TM) Endoscopic Suturing System, the OverStitch Sx(TM) Endoscopic Suturing System and the ORBERA(R) Intragastric Balloon. Apollo is dedicated to revolutionizing patient care through the development of endoscopic surgery. For more information, visit the company's website at

Applied Energetics Inc. (OTCQB: AERG)

Applied Energetics Inc. (OTCQB: AERG) specializes in the development and manufacture of advanced high-performance lasers, high voltage electronics, advanced optical systems and integrated guided energy systems for defense, aerospace, industrial and scientific customers worldwide. Applied Energetics pioneered and holds all crucial intellectual property rights to the development and use of laser guided energy technology and related solutions for commercial, defense and security applications and is protected by 26 patents and 11 additional government sensitive patent applications. The company's 11 GSPA's are held under secrecy orders of the U.S. government and allow Applied Energetics greatly extended protection rights. For more information, visit the company's website at

Aptorum Group Limited (NASDAQ: APM)

Aptorum Group Limited (NASDAQ: APM) is a biopharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle current unmet medical needs. Aptorum Group is pursuing therapeutic projects in neurology, infectious diseases, gastroenterology, oncology and other disease. The company's current drug pipeline includes indications in orphan diseases, infectious diseases and metabolic diseases, a number of which are targeted to enter clinical trial phases. Aptorum Group is also launching a women's health supplement, dioscorea opposita bioactive nutraceutical tablets, marketed under the brand name NativusWell. To date, Aptorum has obtained 11 exclusively licensed technologies in the areas of neurology, infectious diseases, gastroenterology, oncology, surgical robotics and natural health. For more information, visit the company's website at

AquaBounty Technologies Inc. (NASDAQ: AQB)

AquaBounty Technologies Inc. (NASDAQ: AQB) is a leader in science-based aquaculture, leveraging decades of technology expertise to deliver game changing solutions that solve global problems while improving efficiency, sustainability and profitability. AquaBounty provides fresh Atlantic salmon to nearby markets by raising its fish in carefully monitored, land-based fish farms through a safe, secure and sustainable process. With land-based Recirculating Aquaculture System farms located close to key consumption areas in Indiana and Prince Edward Island, Canada, AquaBounty is raising nutritious salmon that is free of disease and antibiotics, resulting in a radically reduced carbon footprint with no risk of pollution to marine ecosystems as compared to traditional sea-cage farming. For more information, visit the company's website at

Arch Therapeutics Inc. (OTCQB: ARTH)

Arch Therapeutics Inc. (OTCQB: ARTH) is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform with the goal of making care faster and safer for patients. Arch's development stage product candidates include AC5 Advanced Wound System, AC5 Topical Hemostat, AC5-G and AC5 Surgical Hemostat. The U.S. Food and Drug Administration (FDA) has provided clearance to market AC5(R) Topical Gel to be used in the management of partial and full-thickness wounds, such as pressure sores, leg ulcers, diabetic ulcers and surgical wounds. For more information, visit the company's website at

Artelo Biosciences Inc. (NASDAQ: ARTL)

Artelo Biosciences Inc. (NASDAQ: ARTL) is a biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics targeting the endocannabinoid system and related biological signaling pathways. Artelo is applying true biopharma discipline toward rapidly advancing a diverse portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including anorexia, cancer, pain and inflammation. Led by proven biopharmaceutical executives collaborating with highly respected researchers and technology experts, the company applies leading edge scientific, regulatory and commercial discipline to develop high-impact therapies. For more information, visit the company's website at

Assure Holdings Corp. (OTCQB: ARHH)

Assure Holdings Corp. (OTCQB: ARHH) works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services supporting intraoperative neuromonitoring activities during invasive surgeries. Assure employs its own staff of technologists and uses its own state-of-the-art monitoring equipment, handles 100% of intraoperative neuromonitoring scheduling and setup, and bills for all technical services provided. Assure Neuromonitoring is recognized as providing the highest level of patient care in the industry and has earned the Joint Commission's Gold Seal of Approval. For more information, visit the company's website at

Asure Software Inc. (NASDAQ: ASUR)

Asure Software Inc. (NASDAQ: ASUR) sees human capital management (HCM) through the lens of entrepreneurs and executives with an owner's mentality. Asure's clients include more than 60,000 small and mid-sized businesses, helping each to develop their "human capital" to get to the next level, stay compliant and allocate their time, money and technology toward growth. Asure's HCM solution includes Asure Payroll and Tax, Asure HR and Asure Time and Attendance. The company's Asure HRServices offer ranges from online compliance tools to a fully outsourced HR department. For more information, visit the company's website at

Atomera Inc. (NASDAQ: ATOM)

Atomera Inc. (NASDAQ: ATOM) is a semiconductor materials and intellectual property licensing company focused on deploying its proprietary technology into the more than $350 billion semiconductor industry. Atomera has developed Mears Silicon Technology(TM), which increases performance and power efficiency in semiconductor transistors. Mears Silicon Technology can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-¬scaling technologies already in the semiconductor industry roadmap. For more information, visit the company's website at

Atossa Therapeutics Inc. (NASDAQ: ATOS)

Atossa Therapeutics Inc. (NASDAQ: ATOS) is a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need. Atossa's current focus is on COVID-19 and breast cancer. Atossa believes its innovative therapies and delivery methods can benefit COVID-19 patients and transform breast cancer treatment – with the goal of preventing breast cancer from developing in the first place. The company has two COVID-19 therapeutic programs under development and is developing a drug to reduce mammographic breast density. For more information, visit the company's website at

Aurora Solar Technologies Inc. (TSX.V: ACU)

Aurora Solar Technologies Inc. (TSX.V: ACU) is a leader in the development and delivery of inline process measurement, analysis and control systems for solar cell manufacturers. Aurora believes that solar power will dominate the renewable energy field, and its mission is to bring quality and profitability to every customer through superior control of critical processes during solar cell manufacturing. Aurora's products are used by some of the world's most advanced and respected solar cell manufacturers. With headquarters near Vancouver, Aurora has operations in Shanghai and partners in all major solar manufacturing markets. For more information, visit the company's website at

AutoWeb Inc. (NASDAQ: AUTO)

AutoWeb Inc. (NASDAQ: AUTO) is a robust digital marketing platform providing high quality consumer leads, clicks and associated marketing services to automotive dealers and manufacturers throughout the United States. The company also provides consumers with robust and original online automotive content to help them make informed car-buying decisions. AutoWeb pioneered the automotive internet in 1995 and has since helped tens of millions of automotive consumers research vehicles; connected thousands of dealers nationwide with motivated car buyers; and helped every major automaker successfully market its brand online. For more information, visit the company's website at

Avivagen Inc. (TSX.V: VIV:CA) (OTCQB: VIVXF)

Avivagen Inc. (TSX.V: VIV) (OTCQB: VIVXF) is a life sciences corporation focused on developing and commercializing immune system improving products for livestock, companion animal and human applications. Avivagen's OxC-beta(TM) technology is derived from Avivagen discoveries about β-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. Through support of immune function, the technology provides a non-antibiotic means of promoting health and growth. OxC-beta(TM) Livestock is a proprietary product shown to be an effective and economical alternative to the antibiotics commonly added to livestock feeds. The product is currently available for sale in the United States, Philippines, Taiwan, New Zealand, Thailand, Mexico, Australia and Malaysia. For more information, visit the company's website at


AYRO Inc. (NASDAQ: AYRO) is a manufacturer of light-duty, emissions-free electric vehicles. Texas-based AYRO designs and delivers compact fleet solutions for use within urban and short-haul markets. Capable of accommodating a broad range of commercial and consumer requirements, AYRO's vehicles are the emerging leaders of safe, affordable, efficient and sustainable logistical transportation. The company was founded in 2017 by entrepreneurs, investors and executives with a passion to create sustainable urban electric vehicle solutions for campus management, last mile delivery, urban commuting and closed campus transport. For more information, visit the company's website at

Aytu BioScience Inc. (NASDAQ: AYTU)

Aytu BioScience Inc. (NASDAQ: AYTU) is a commercial-stage specialty pharmaceutical company focused on commercializing novel products that address significant patient needs. The company currently markets a portfolio of prescription products addressing large primary care and pediatric markets. In addition, Aytu distributes a COVID-19 IgG/IgM rapid test. Aytu also operates a subsidiary focused on consumer health, Innovus Pharmaceuticals Inc., a specialty pharmaceutical company that commercializes, licenses and develops safe and effective consumer health care products designed to improve men's and women's health and vitality. For more information, visit the company's website at

AzurRx BioPharma Inc. (NASDAQ: AZRX)

AzurRx BioPharma Inc. (NASDAQ: AZRX) is a biopharmaceutical company specializing in the research and development of non-systemic biologics for gastrointestinal disorders. The company is focused on the development of its lead drug candidate, MS1819. AzurRx is currently conducting two Phase 2 clinical trials of MS1819: the OPTION 2 monotherapy trial and the combination therapy trial, consisting of MS1819 in conjunction with porcine-derived pancreatic enzyme replacement therapy, the current standard of care. AzurRx is headquartered in New York with scientific operations based in Langlade, France, and clinical operations in Hayward, California. For more information, visit the company's website at

Ballard Power Systems Inc. (NASDAQ: BLDP) (TSX: BLDP)

Ballard Power Systems Inc. (NASDAQ: BLDP) (TSX: BLDP) is a leading global provider of innovative clean energy and fuel cell solutions. The company's vision is to deliver fuel cell power for a sustainable planet. Ballard uses its fuel cell expertise to deliver valuable and innovative solutions to customers globally, create rewarding opportunities for team members, provide extraordinary value to shareholders and power the hydrogen society. Ballard zero-emission PEM fuel cells are enabling electrification of mobility, including buses, commercial trucks, trains, marine vessels, passenger cars, forklift trucks and UAVs. For more information, visit the company's website at


Bel Fuse Inc. (NASDAQ: BELFA) (NASDAQ: BELFB) designs, manufactures and markets a broad array of products that power, protect and connect electronic circuits. These products are primarily used in the networking, telecommunications, computing, military, aerospace, medical, transportation and broadcasting industries. Bel's product groups include magnetic solutions (integrated connector modules, power transformers, power inductors and discrete components), power solutions and protection (front-end, board-mount and industrial power products, module products and circuit protection) and connectivity solutions (expanded beam fiber optic, copper-based, RF and RJ connectors and cable assemblies). The company operates facilities around the world. For more information, visit the company's website at

BioCardia Inc. (NASDAQ: BCDA)

BioCardia Inc. (NASDAQ: BCDA) is a clinical-stage regenerative medicine company. Headquartered in San Carlos, California, BioCardia is developing regenerative biologic therapies to treat cardiovascular disease. The company's CardiAMP autologous and NK1R+ allogenic cell therapies are biotherapeutic platforms currently in clinical development. BioCardia's products include the Helix biotherapeutic delivery system and its steerable guide and sheath catheter portfolio. BioCardia also partners with other biotherapeutic companies to provide its Helix system and clinical support to their programs studying therapies for the treatment of heart failure, chronic myocardial ischemia and acute myocardial infarction. For more information, visit the company's website at

Biocept Inc. (NASDAQ: BIOC)

Biocept Inc. (NASDAQ: BIOC) is a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information to improve patient outcomes. As a molecular diagnostics company with commercialized assays for lung, breast, gastric, colorectal and prostate cancers and melanoma, Biocept leverages its proprietary liquid biopsy technology to provide physicians with data for treating and monitoring patients diagnosed with cancer. The company's patented Target Selector(TM) liquid biopsy technology platform captures and analyzes tumor-associated molecular markers in both circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA). With thousands of tests performed, the platform has demonstrated the ability to identify cancer mutations and alterations to inform physicians about a patient's disease and therapeutic options. Biocept is also providing highly accurate PCR-based COVID-19 testing with a quick turnaround time and is developing its own specimen collection kits. For more information, visit the company's website at

BioLargo Inc. (OTCQB: BLGO)

BioLargo Inc. (OTCQB: BLGO) is a sustainable science, technology and full-service environmental engineering company that "makes life better" by delivering world-class products and services across a broad range of industries. As an innovator of technology-based products and sustainable environmental engineering solutions, BioLargo is driven to deliver clean water, clean air and advanced antimicrobials for health care. The BioLargo family of companies includes BioLargo Engineering, Science & Technologies; BioLargo Water; Clyra Medical Technologies Inc.; and Odor-No-More (ONM) Environmental Products and Services. For more information, visit the company's website at

Biomerica Inc. (NASDAQ: BMRA)

Biomerica Inc. (NASDAQ: BMRA) is a global biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care (in home and in physicians' offices) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. The company's products are designed to enhance the health and well-being of people, enable prevention and early detection of disease and reduce total health care costs. Biomerica primarily focuses on gastrointestinal and inflammatory diseases where the company has multiple diagnostic and therapeutic products in development. For more information, visit the company's website at

BioSig Technologies Inc. (NASDAQ: BSGM)

BioSig Technologies Inc. (NASDAQ: BSGM) is a medical device company commercializing a proprietary technology platform designed to improve the $4 billion electrophysiology (EP) marketplace. BioSig's biomedical signal processing platform is designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals. The company's first trademarked product, PURE EP System, is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in EP laboratories. For more information, visit the company's website at

BioSyent Inc. (TSX.V: RX)

BioSyent Inc. (TSX.V: RX) is a specialty pharmaceutical company engaged in developing pharmaceutical and health care products for the Canadian market. The company's products include FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Aguettant System and Cysview. BioSyent is focused on commercializing products that provide a distinguishable benefit to patients and their health care providers. Through its subsidiaries, BioSyent sources, acquires or in-licenses pharmaceutical products and markets the products to pharmacies and health care professionals in all 10 Canadian provinces. BioSyent is actively sought out as the Canadian market partner of choice by brand innovators with niche or specialty products looking for a trusted partner. For more information, visit the company's website at

Blink Charging Co. (NASDAQ: BLNK) (NASDAQ: BLNKW)

Blink Charging Co. (NASDAQ: BLNK) (NASDAQ: BLNKW) is a leading owner, operator and provider of electric vehicle (EV) charging equipment and services. Blink Charging has deployed over 23,000 charging stations, many of which are networked EV charging stations, enabling EV drivers to easily charge at any of the company's charging locations worldwide. Blink Charging's principal line of products and services includes its Blink EV charging network ("Blink Network"), EV charging equipment and EV charging services. The Blink Network uses proprietary, cloud-based software that operates, maintains and tracks the EV charging stations connected to the network and the associated charging data. With global EV purchases forecast to rise to 10 million vehicles by 2025 from approximately 2 million in 2019, the company has established key strategic partnerships for rolling out adoption across numerous locations. For more information, visit the company's website at

BlueCity Holdings Ltd. (NASDAQ: BLCT)

BlueCity Holdings Ltd. (NASDAQ: BLCT) is a world-leading online LGBTQ platform, providing a full suite of services aimed at empowering the LGBTQ community in every aspect of their daily lives. As a central hub of BlueCity's services and platforms, the Blued mobile app allows its users to connect with each other, express themselves and access professional health-related services and family planning consulting services at their fingertips. Blued has connected more than 49 million registered users worldwide as of March 2020 and has a leading foothold in many markets. For more information, visit the company's website at

Blueknight Energy Partners L.P. (NASDAQ: BKEP) (NASDAQ: BKEPP)

Blueknight Energy Partners L.P. (NASDAQ: BKEP) (NASDAQ: BKEPP) owns and operates a diversified portfolio of complementary midstream energy assets, offering terminalling, storage, processing, gathering and transportation services. The company's strategically located assets allow Blueknight to be a leading provider of midstream services in the energy industry. Blueknight provides services to its customers by focusing on two operational areas: product terminalling (liquid asphalt and crude oil) and crude oil logistics (pipeline transportation and trucking). Blueknight customers include independent oil and gas producers, petroleum product wholesalers and distributors, refiners and energy traders. For more information, visit the company's website at

BOQI International Medical Inc. (NASDAQ: BIMI)

BOQI International Medical Inc. (NASDAQ: BIMI) offers a broad range of consumer-directed health products and related services, including medical, pharmacy and behavioral health plans, chronic disease management services and health information technology products and services. BOQI International Medical is community based and locally focused, engaging consumers and providing them with more affordable, accessible, simple and seamless care, when and where they need it. Formerly known as NF Energy Saving Corporation, the company was founded in 2006. In February 2019, the board of directors was reorganized following efforts led by Yongquan Bi, the company's new chairman, with a renewed focus on the health industry. For more information, visit the company's website at

Bright Mountain Media Inc. (OTCQB: BMTM)

Bright Mountain Media Inc. (OTCQB: BMTM) is an end-to-end digital media and advertising services platform, efficiently connecting brands with targeted consumer demographics. By removing middlemen in the advertising services process, Bright Mountain Media efficiently connects brands with targeted consumer demographics while maximizing revenue to publishers. Bright Mountain Media's assets include the Bright Mountain LLC ad network, MediaHouse, Oceanside and Wild Sky Media, including 24 owned and/or managed websites and 15 CTV apps. Bright Mountain Media's mission is to simplify the entire digital advertising ecosystem. For more information, visit the company's website at

C-Bond Systems Inc. (OTC: CBNT)

C-Bond Systems Inc. (OTC: CBNT) is an advanced nanotechnology company and marketer of the patented C-Bond technology, developed in conjunction with Rice University and independently proven to significantly strengthen glass in key automotive and structural applications. Based in Houston, Texas, the company's transportation solutions group sells C-Bond NanoShield(R), a liquid solution applied directly to automotive windshields, through distributors. The company's safety solutions group sells ballistic-resistant glass solutions and FN NANO coating directly to private enterprises, schools, hospitals and government agencies. For more information, visit the company's website at

Caladrius Biosciences Inc. (NASDAQ: CLBS)

Caladrius Biosciences Inc. (NASDAQ: CLBS) is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease. The company is developing a first-in-class cell therapy product that is based on the notion that the human body contains finely tuned mechanisms for self-repair. Caladrius Biosciences' technology leverages and enables these mechanisms in the form of specific cells, using formulations and modes of delivery unique to each medical indication. The company's current product candidates include CLBS119, a CD34+ cell therapy product candidate for the repair of lung damage found in patients with severe COVID-19 infection who experienced respiratory failure, as well as three developmental treatments for ischemic diseases based on its CD34+ cell therapy platform. For more information, visit the company's website at

Calyxt Inc. (NASDAQ: CLXT)

Calyxt Inc. (NASDAQ: CLXT) is a plant-based technology company headquartered in Roseville, Minnesota. The company innovates, together with like-minded partners, to deliver plant-based products with wellness and sustainability benefits. Calyxt uses cutting edge plant breeding techniques to innovate and develop solutions to address unmet consumer and market demands. Calyxt accelerates the process of breeding stronger, more sustainable, higher-yielding plants with an advanced breeding technology (Transcription Activator-Like Effector Nuclease, or TALEN) that allows for precision targeting of existing genes within a plant's genome to develop better-tasting plant proteins and increase speed to market. For more information, visit the company's website at


Camtek Ltd. (NASDAQ: CAMT) (TASE: CAMT) is a leading manufacturer of metrology and inspection equipment and a provider of software solutions. Camtek serves the advanced packaging, memory, CMOS image sensors, MEMS, RF and other segments of the mid-end of the semiconductor industry. Headquartered in Israel, Camtek provides dedicated solutions and crucial yield-enhancement data, enabling manufacturers to improve yield and drive down production costs. With eight offices around the world, Camtek is a best-in-class sales and customer support organization, providing tailor-made solutions in line with customers' requirements. For more information, visit the company's website at

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI)

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI) is an advanced clinical-stage drug development company with a platform technology designed to address multibillion-dollar markets in the treatment of cancer, inflammatory disease and COVID-19. The company's lead drug candidate, Piclidenoson, is currently in Phase III trials for rheumatoid arthritis and psoriasis. Can-Fite's liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC) and successfully achieved its primary endpoint in a Phase II trial for treating nonalcoholic steatohepatitis (NASH). Namodenoson has been granted Orphan Drug Designation in the U.S. and Europe and Fast Track Designation as a second-line treatment for HCC by the U.S. Food and Drug Administration. Namodenoson has also shown proof of concept to potentially treat other cancers, including colon, prostate and melanoma. CF602, the company's third drug candidate, has shown efficacy in treating erectile dysfunction. For more information, visit the company's website at

Capstone Turbine Corp. (NASDAQ: CPST)

Capstone Turbine Corp. (NASDAQ: CPST) is the world's leading producer of highly efficient, low-emission, resilient microturbine energy systems. Capstone microturbines serve multiple vertical markets worldwide, including natural resources, energy efficiency, renewable energy, critical power supply, transportation and microgrids. Capstone offers a comprehensive product lineup via its direct sales team, as well as its global distribution network. Capstone provides scalable solutions from 30 kW to 10 MW that operate on a variety of fuels and are the ideal solution for today's multi-technology distributed power generation projects. To date, Capstone has shipped nearly 10,000 units to 83 countries; in FY20, the company saved customers an estimated $219 million in annual energy costs and 368,000 tons of carbon. For customers with limited capital or short-term needs, Capstone offers rental systems. For more information, visit the company's website at

CEL-SCI Corp. (NYSE American: CVM)

CEL-SCI Corp. (NYSE American: CVM) believes boosting a patient's immune system while it is still intact should provide the greatest possible impact on survival. Therefore, in its global pivotal Phase 3 study, CEL-SCI treated patients who are newly diagnosed with advanced primary squamous cell carcinoma (cancer) of the head and neck with Multikine (leukocyte interleukin, injection) first, before they received surgery, radiation and/or chemotherapy. This approach is unique. Most other cancer immunotherapies are administered only after conventional therapies have been tried and/or failed. Multikine has received Orphan Drug Designation from the FDA for neoadjuvant therapy in patients with squamous cell carcinoma of the head and neck. Multikine is designed to help the immune system 'see' the tumor at a time when the immune system is still relatively intact and thereby thought to be better able to mount an attack on the tumor. For more information, visit the company's website at

Cemtrex Inc. (NASDAQ: CETX)

Cemtrex Inc. (NASDAQ: CETX) is a leading multi-industry technology company that is driving innovation in markets such as internet of things (IoT), augmented and virtual reality (AR & VR), and artificial intelligence and computer vision (AI & CV) in a wide range of sectors, including consumer products, industrial manufacturing, digital applications, and intelligent security and surveillance systems. For more information, visit the company's website at

Chicken Soup for the Soul Entertainment Inc. (NASDAQ: CSSE)

Chicken Soup for the Soul Entertainment Inc. (NASDAQ: CSSE) operates streaming video-on-demand networks (VOD). The company owns a majority stake in Crackle Plus, a company formed with Sony Pictures Television, which owns and operates a variety of ad-supported and subscription-based VOD networks, including Crackle, Popcornflix, Popcornflix Kids, Truli, Pivotshare, Españolflix and FrightPix. The company also acquires and distributes video content through its Screen Media subsidiary and produces original long- and short-form content through Landmark Studio Group, its Chicken Soup for the Soul Originals division and Chicken Soup for the Soul Entertainment is a subsidiary of Chicken Soup for the Soul LLC, which publishes the famous book series and produces super-premium pet food under the Chicken Soup for the Soul brand name. For more information, visit the company's website at

ChromaDex Corp. (NASDAQ: CDXC)

ChromaDex Corp. (NASDAQ: CDXC) is a science-based integrated nutraceutical company devoted to improving the way people age. ChromaDex scientists partner with leading universities and research institutions worldwide to discover, develop and create solutions to deliver the full potential of NAD and its impact on human health. Its flagship ingredient, NIAGEN nicotinamide riboside, sold directly to consumers as TRU NIAGEN, is backed with clinical and scientific research, as well as extensive IP protection. TRU NIAGEN is helping the world age better. For more information, visit the company's website at

Cinedigm Corp. (NASDAQ: CIDM)

Cinedigm Corp. (NASDAQ: CIDM) is a leading independent entertainment studio in North America, widely recognized for its film/TV/digital production, digital cinema, OTT channels, and content and marketing distribution. For more than 20 years, Cinedigm has led the digital transformation of the entertainment industry. Today, Cinedigm entertains hundreds of millions of consumers around the globe by providing premium content, streaming channels and technology services to the world's largest media, technology and retail firms. For more information, visit the company's website at

Citius Pharmaceuticals Inc. (NASDAQ: CTXR)

Citius Pharmaceuticals Inc. (NASDAQ: CTXR) is a late-stage specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives and cancer care. Citius is focused on the development and commercialization of important new drug products for growing markets. The company is currently advancing three proprietary product candidates: Mino-Lok(R), CITI-002 (halobetasol-lidocaine formulation) and CITI-101 (Mino-Wrap). Citius believes the markets for its products are large and underserved by the current standard of care. For more information, visit the company's website at


CLPS Inc. (NASDAQ: CLPS), headquartered in Hong Kong, is a global leading information technology ("IT") consulting and solutions service provider focusing on the banking, insurance and financial service sectors. The company serves as an IT solutions provider to a growing network of clients in the global financial service industry, including large financial institutions in the U.S., Europe, Australia and Hong Kong SAR, as well as People's Republic of China-based IT centers. The company maintains 18 delivery and/or research and development centers to serve different customers in various geographic locations. Mainland China centers are located in Shanghai, Beijing, Dalian, Tianjin, Baoding, Chengdu, Guangzhou, Shenzhen, Hangzhou and Suzhou. The remaining eight global centers are located in Hong Kong SAR, the U.S., the UK, Japan, Singapore, Malaysia, Australia and India. For more information, visit the company's website at

Conversion Labs Inc. (OTCQB: CVLB)

Conversion Labs Inc. (OTCQB: CVLB) is a telemedicine company with a portfolio of online direct-to-consumer brands. The company's brands combine virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers across the United States. Conversion Labs is applying its direct-response marketing expertise to health care and providing a convenient, cost-effective and smarter way for consumers to access high-quality OTC products and prescription medications. For more information, visit the company's website at

Crown ElectroKinetics Corp. (OTCQB: CRKN)

Crown ElectroKinetics Corp. (OTCQB: CRKN) is a Corvallis-based startup with a novel approach to the growing smart glass industry. The company is a global leader in DynamicTint(TM). Originally invented by Hewlett-Packard, the company's technology allows any glass surface to transition between clear and dark in seconds. DynamicTint allows windows to transition from transparent to black. With applications for a wide array of windows, including commercial buildings, automotive sunroofs and residential skylights, Crown partners with leading glass and film manufacturers, licensing its intellectual property for mass production. At the core of Crown's technology is a thin film that is powered by electrically charged pigment, which not only replaces common window tints but is also a more sustainable alternative to traditional window treatments. The company is supported by a robust patent portfolio. For more information, visit the company's website at

CynergisTek Inc. (NYSE American: CTEK)

CynergisTek Inc. (NYSE American: CTEK) is a leader in information security, privacy and compliance. CynergisTek is a top-ranked cybersecurity firm dedicated to serving the information assurance needs of the health care industry. CynergisTek offers specialized services and solutions to help organizations achieve privacy, security and compliance goals. Since 2004, the company has served as a partner to hundreds of health care organizations and is dedicated to supporting and educating the industry by contributing to relevant industry associations. The company has been recognized by KLAS as a top-performing firm in health care cybersecurity and was named the '2019 Top Healthcare Cybersecurity Consultants' by the Black Book IT Advisory Outcomes Survey. For more information, visit the company's website at

Data443 Risk Mitigation Inc. (OTC: ATDS)

Data443 Risk Mitigation Inc. (OTC: ATDS) is an industry leader in all things data security, providing software and services to enable secure data across local devices, networks, clouds and databases, both at rest and in flight. Its suite of products and services is highlighted by: ARALOC, a market leading secure, cloud-based platform for the management, protection and distribution of digital content to desktop and mobile devices, which protects an organization's confidential content and intellectual property assets from leakage – malicious or accidental – without impacting collaboration between all stakeholders; ArcMail, a leading provider of simple, secure and cost-effective enterprise data retention management, archiving and management solutions; and ClassiDocs(TM), the company's award-winning data classification and governance technology. For more information, visit the company's website at

Delcath Systems Inc. (NASDAQ: DCTH)

Delcath Systems Inc. (NASDAQ: DCTH) is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. The company's investigational product, melphalan hydrochloride for injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS), is designed to administer high-dose chemotherapy to the liver while minimizing systemic exposure and associated side effects. In addition to the Phase 3 FOCUS trial, the company has initiated a global Phase 3 clinical trial for intrahepatic cholangiocarcinoma (ICC) called 'The ALIGN Trial'. Delcath is also evaluating other forms of metastatic liver cancers. For more information, visit the company's website at

Digirad Corp. (NASDAQ: DRAD)

Digirad Corp. (NASDAQ: DRAD) is a diversified holding company with three divisions: health care, building and construction, and real estate and investments. Digirad is the nationwide leader in delivering diagnostic expertise on an as-needed, when-needed, where-needed basis. Recognized by Insights Success Magazine as one of the 'Top 10 Fastest Growing Healthcare Solution Provider Companies', Digirad makes health care convenient through its unique model of on-demand, direct to point-of-service health care to thousands of providers across the country. For more information, visit the company's website at

Digital Ally Inc. (NASDAQ: DGLY)

Digital Ally Inc. (NASDAQ: DGLY) specializes in the design and manufacture of the highest quality video recording equipment and video analytic software. Digital Ally pushes the boundaries of technology in industries such as law enforcement, emergency management, fleet safety and security. Digital Ally's complete product solutions include vehicle and body cameras, flexible software storage, automatic recording technology and various critical safety products. These products work seamlessly together and are simple to install and operate. In addition, Digital Ally recently launched two new product lines, including a non-contact thermometer/controlled-entry device under the company's ThermoVu brand and an EPA category IV disinfectant/sanitizer under the company's Shield brand. Digital Ally products are sold by domestic direct sales representatives and international distributors worldwide. For more information, visit the company's website at

Dolphin Entertainment Inc. (NASDAQ: DLPN)

Dolphin Entertainment Inc. (NASDAQ: DLPN) is a leading independent entertainment marketing and premium content production company. Through its subsidiaries, 42West, The Door and Shore Fire Media, Dolphin provides expert strategic marketing and publicity services to many of the top brands, both individual and corporate, in the film, television, music and hospitality industries. In December 2019, all three PR firms were ranked among The Observer's 'Power 50 PR Firms in the United States', an unprecedented achievement. Dolphin's acquisition of Viewpoint Creative adds full-service creative branding and production capabilities to its marketing group. Dolphin's legacy content production business, founded by Emmy-nominated CEO Bill O'Dowd, has produced multiple feature films and award-winning digital series. For more information, visit the company's website at

Driven Deliveries Inc. (OTCQB: DRVD)

Driven Deliveries Inc. (OTCQB: DRVD) is one of California's fastest-growing online cannabis retailers and direct-to-consumer logistics companies. Driven is one of the first publicly traded cannabis delivery services operating within the United States. Founded by experienced technology and cannabis executives, the company provides e-commerce solutions, online sales and on-demand cannabis delivery in select cities where allowed by law. Driven offers legal cannabis consumers the ability to purchase and receive their marijuana in a fast and convenient manner. By leveraging consumer trends and offering a proprietary, turnkey delivery system to its customers, management believes it is uniquely positioned to best serve the needs of the emerging cannabis industry and capture notable market share within the sector. For more information, visit the company's website at

electroCore Inc. (NASDAQ: ECOR)

electroCore Inc. (NASDAQ: ECOR) is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation (nVNS) therapy, which is initially focused on the treatment of multiple conditions in neurology. The company's current indications are for the preventative treatment of cluster headache and acute treatment of migraine and episodic cluster headache. electroCore has secured an extensive intellectual property portfolio, with more than 200 patents and patent applications worldwide. These patents and patent applications cover many critical areas of its technology, including the proprietary signal, methods of treatment, non-invasive delivery means and mechanisms of central action. In July 2020, the U.S. Food and Drug Administration ("FDA") granted the Company an Emergency Use Authorization (EUA) authorizing the use of the Company's gammaCore Sapphire(TM) CV nVNS therapy at home or in a healthcare setting to acutely treat adult patients with known or suspected COVID-19 who are experiencing exacerbation of asthma-related dyspnea and reduced airflow, and for whom approved drug therapies are not tolerated or provide insufficient symptom relief.For more information, visit the company's website at

Energous Corp. (NASDAQ: WATT)

Energous Corp. (NASDAQ: WATT) is leading the next generation of wireless charging with its award-winning WattUp(R) technology, which supports fast, efficient contact-based charging, as well as charging at a distance. WattUp is a scalable, RF-based wireless charging technology that offers substantial improvements in contact-based charging efficiency, foreign object detection, orientation freedom and thermal performance compared to older, coil-based charging technologies. The technology can be designed into many different-sized electronic devices for the home and office, as well as the medical, industrial, retail and automotive industries, and it ensures interoperability across products. Energous develops silicon-based wireless power transfer (WPT) technologies and customizable reference designs. These include innovative silicon chips, antennas and software for a large variety of applications, such as smartphones, fitness trackers, hearables, medical sensors and more. For more information, visit the company's website at

Energy Focus Inc. (NASDAQ: EFOI)

Energy Focus Inc. (NASDAQ: EFOI) is an industry-leading innovator of sustainable LED lighting and lighting control technologies and solutions. As the creator of the first flicker-free LED lamps, Energy Focus develops high-quality LED lighting products that provide extensive energy and maintenance savings, as well as aesthetics, safety, health and sustainability benefits over conventional lighting. The company's EnFocus(TM) lighting control platform enables existing and new buildings to provide quality, convenient and affordable dimmable and color tunable circadian and human-centric lighting capabilities. Energy Focus customers include U.S. and foreign navies; U.S. federal, state and local governments; health care and educational institutions; and Fortune 500 companies. Since 2007, Energy Focus has installed approximately 900,000 lighting products across the U.S. Navy fleet, saving more than five million gallons of fuel and 300,000 man-hours in lighting maintenance annually. For more information, visit the company's website at

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR)

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) is a leading U.S.-based uranium mining company, supplying U3O8 to major nuclear utilities. The company also produces vanadium from certain of its projects, as market conditions warrant. Its corporate offices are in Lakewood, Colorado, near Denver, and all of its assets and employees are in the United States. Energy Fuels holds three of America's key uranium production centers: the White Mesa Mill in Utah, the Nichols Ranch in-situ recovery ("ISR") Project in Wyoming and the Alta Mesa ISR Project in Texas. In addition, Energy Fuels has one of the largest NI 43-101-compliant uranium resource portfolios in the U.S. and several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. For more information, visit the company's website at

Enthusiast Gaming Holdings Inc. (TSX: EGLX) (OTCQB: ENGMF)

Enthusiast Gaming Holdings Inc. (TSX: EGLX) (OTCQB: ENGMF) is building the world's largest platform of communities for gamers and esports fans. Already the largest gaming platform in North America and the United Kingdom, the company's business is comprised of three main pillars: media, entertainment and esports. Enthusiast Gaming's digital media platform includes approximately 100 gaming-related websites and 900 YouTube channels, which collectively reach 160 million visitors monthly. The media platform generates over 30 billion ad requests and approximately a billion views per month. Enthusiast's esports division, Luminosity Gaming, is a leading global esports franchise that consists of seven professional esports teams under ownership and management. Enthusiast Gaming's entertainment division, EG Entertainment, owns and operates Canada's largest gaming expo, Enthusiast Gaming Live Expo; EGLX; and the largest mobile gaming event in Europe, Pocket Gamer Connects. For more information, visit the company's website at

EnviroLeach Technologies Inc. (CSE: ETI) (OTCQB: EVLLF)

EnviroLeach Technologies Inc. (CSE: ETI) (OTCQB: EVLLF) is engaged in the development and commercialization of environmentally friendly formulas and technologies for the treatment of materials in the mining and recycling sectors. Using its proprietary non-cyanide, water-based, neutral pH treatment process, EnviroLeach extracts precious metals from ores, concentrates and e-waste using only FDA-approved additives and ambient temperature water. Backed by the momentum of a first-class staff of scientists and engineers, tens of thousands of individual assays, independent validations, strategic partners and over $20 million in research and development, EnviroLeach's technology is emerging as a potential new standard for the provision of eco-friendly methods for the hydrometallurgical extraction of precious metals in both the conventional mining and e-waste sectors. For more information, visit the company's website at

Envision Solar International Inc. (NASDAQ: EVSI)

Envision Solar International Inc. (NASDAQ: EVSI) is the leading producer of unique and sustainable infrastructure products for electric vehicle charging, energy security and outdoor media, including the EV ARC(TM) and the Solar Tree(R) with EnvisionTrak(TM) patented solar tracking, SunCharge(TM) solar electric vehicle charging, ARC(TM) technology energy storage and EnvisionMedia(TM) solar advertising displays. Based in San Diego, California, the company produces 'made in America' products. For more information, visit the company's website at

Esports Entertainment Group Inc. (NASDAQ: GMBL)

Esports Entertainment Group Inc. (NASDAQ: GMBL) is a licensed online gambling company with a specific focus on esports wagering and 18+ gaming. Esports Entertainment offers fantasy, pools, fixed odds and exchange-style wagering on esports events through a licensed, regulated and secure platform to the global esports audience. In addition, Esports Entertainment intends to offer users from around the world the ability to participate in multiplayer mobile and PC video game tournaments for cash prizes. Esports Entertainment is led by a team of industry professionals and technical experts from the online gambling and video game industries, as well as esports. The company holds a license to conduct online gambling and 18+ gaming on a global basis in Curacao, Kingdom of the Netherlands. The company maintains offices in Malta. For more information, visit the company's website at

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN)

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) is a leading computational biology company aiming to revolutionize product development for life science-based industries, including human health, agriculture and industrial applications. Incorporating a deep understanding of biology and leveraging big data and artificial intelligence, Evogene established its unique technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life science products based on microbes, small molecules and genetic elements as the core components for such products. Evogene holds a number of subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. For more information, visit the company's website at

Excellon Resources Inc. (TSX: EXN) (OTC: EXLLF)

Excellon Resources Inc. (TSX: EXN) (OTC: EXLLF) operates with a vision to create wealth by realizing strategic opportunities through discipline and innovation for the benefit of its employees, communities and shareholders. The company is advancing a precious metals growth pipeline that includes: Platosa, Mexico's highest-grade silver mine since production commenced in 2005; Kilgore, a high-quality gold development project in Idaho with strong economics and significant growth and discovery potential; and an option on Silver City, a high-grade epithermal silver district in Saxony, Germany, with 750 years of mining history and no modern exploration. The company also aims to continue capitalizing on current market conditions by acquiring undervalued projects. For more information, visit the company's website at

Exro Technologies Inc. (TSX.V: EXRO) (OTCQB: EXROF)

Exro Technologies Inc. (TSX.V: EXRO) (OTCQB: EXROF) is a clean tech company that has developed a new class of control technology for electric powertrains. Exro's advanced motor control technology – its 'Coil Driver' – expands the capabilities of electric motors and powertrains. The Coil Driver enables two separate torque profiles within a given motor. The first is calibrated for low speed and high torque, while the second provides expanded operation at high speed. The ability to change configuration allows efficiency optimization for each operating mode, resulting in overall reductions in energy consumption. The controller automatically and seamlessly selects the appropriate configuration in real time so that torque demand and efficiency are optimized. Implementation of Exro's technology can yield the following results: increased drive cycle efficiency, reduced system volume, reduced weight, expanded torque and enhanced speed capabilities. For more information, visit the company's website at

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) is a technology company engaged in the design, development and commercialization of sensors systems for the automotive industry. Through the company's wholly owned subsidiaries, Foresight Automotive Ltd. and Eye-Net Mobile Ltd., Foresight develops both 'in-line-of-sight' vision systems and 'beyond-line-of-sight' cellular-based applications. Foresight's vision sensor is a four-camera system based on 3D video analysis, advanced algorithms for image processing and sensor fusion. Eye-Net Mobile's cellular-based application is a V2X (vehicle-to-everything) accident prevention solution based on real-time spatial analysis of clients' movement. The company's systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is targeting the advanced driver assistance systems (ADAS), as well as semi-autonomous and autonomous vehicle markets, and predicts that its systems will revolutionize automotive safety. For more information, visit the company's website at

Fortress Biotech Inc. (NASDAQ: FBIO)

Fortress Biotech Inc. (NASDAQ: FBIO) is an innovative biopharmaceutical company that was recently ranked number 10 in Deloitte's 2019 Technology Fast 500(TM). Fortress is focused on acquiring, developing and commercializing high-potential marketed and development-stage drugs and drug candidates. The company has five marketed prescription pharmaceutical products and over 25 programs in development at Fortress, at its majority-owned and majority-controlled partners, and at partners it founded and in which it holds significant minority ownership positions. Such product candidates span six large-market areas, including oncology, rare diseases and gene therapy. Fortress has established partnerships with some of the world's leading academic research institutions and biopharmaceutical companies, including Alexion Pharmaceuticals Inc., AstraZeneca, City of Hope, Fred Hutchinson Cancer Research Center, InvaGen Pharmaceuticals Inc. (a subsidiary of Cipla Ltd.), St. Jude Children's Research Hospital and Nationwide Children's Hospital. For more information, visit the company's website at


GAN Ltd. (NASDAQ: GAN) is an award-winning provider of enterprise software-as-a-service ("SaaS") solutions for online casino gaming, commonly referred to as iGaming, and online sports betting applications. The GAN technology platform, which is marketed as the GameSTACK internet gaming ecosystem platform, has been deployed in both Europe and the U.S. However, the company is primarily focused on enabling the U.S. casino industry's ongoing digital transformation, which is accelerating following the repeal of a federal ban on sports betting in May 2018. GAN's customers rely on its software to run their online casinos and sportsbooks legally, profitably and with engaging content. For more information, visit the company's website at

Genasys Inc. (NASDAQ: GNSS)

Genasys Inc. (NASDAQ: GNSS) is a global provider of critical communications systems and solutions to help keep people safe. Genasys provides a multichannel approach to deliver geotargeted alerts, notifications, instructions and information before, during and after public safety threats and critical business events. The company's unified critical communications platform includes its national emergency warning system (NEWS), personal safety service (PSS), team safety management (TSM), LRAD(R) voice broadcast systems and more. Genasys systems are in service in 72 countries and in more than 450 U.S. cities in diverse applications, including public safety, emergency warning, mass notification, critical event management, defense, law enforcement, homeland security and many more. For more information, visit the company's website at

Genprex Inc. (NASDAQ: GNPX)

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes. Genprex's technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to in-license and develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. The company's lead product candidate, GPX-001 (quaratusugene ozeplasmid), is being evaluated as a treatment for non-small cell lung cancer (NSCLC). In January 2020, the U.S. Food and Drug Administration granted Fast Track Designation for GPX-001 for NSCLC in combination therapy with osimertinib (AstraZeneca's Tagrisso(R)) for patients with EFGR mutations whose tumors progressed after treatment with osimertinib alone. For more information, visit the company's website at

Giga-tronics Inc. (OTCQB: GIGA)

Giga-tronics Inc. (OTCQB: GIGA) produces radar filters and microwave integrated components for use in military defense applications, as well as sophisticated radar and electronic warfare (RADAR/EW) test products primarily used in electronic warfare test and emulation applications. For nearly 40 years, Giga-tronics has been helping solve the world's next-generation radar and electronic warfare problems with state-of-the-art high-speed signal generators, sub-system and sub-assembly, test and measurement equipment. Giga-tronics' product lines include the advanced signal generation and analysis test equipment and the Microsource sub-system and sub-assembly TBRF technology products. For more information, visit the company's website at

GOLO Mobile Inc. (TSX.V: GOLO)

GOLO Mobile Inc. (TSX.V: GOLO) provides a solution for the final 100 feet of last mile delivery for properties via its concierge service, as well as its ability to manage all packages and deliveries that enter a property. The company's focus is on office buildings, residential towers, corporate campuses, hospitals, airports and other highly populated areas. GOLO is publicly traded on the TSX Venture Exchange, and its controlling shareholder is controlled indirectly by affiliates of Blackstone Group L.P. and the funds comprising CVC Capital Partners VI. For more information, visit the company's website at


GreenBox POS (OTCQB: GRBX) is an emerging financial technology company leveraging proprietary blockchain security to build customized payment solutions. The company's applications enable an end-to-end suite of turnkey financial products, reducing fraud and improving the efficiency of handling large-scale commercial processing volumes for its merchant clients globally. GreenBox leverages clients' business potential through advanced blockchain-powered technology. For more information, visit the company's website at

Greenbrook TMS Inc. (TSX: GTMS)

Greenbrook TMS Inc. (TSX: GTMS) operates through 125 company-operated treatment centers and is a leading provider of transcranial magnetic stimulation ("TMS") therapy, an FDA-cleared, noninvasive therapy for the treatment of major depressive disorder and other mental health disorders in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided more than 460,000 TMS treatments to over 13,000 patients struggling with depression. For more information, visit the company's website at

GSI Technology Inc. (NASDAQ: GSIT)

GSI Technology Inc. (NASDAQ: GSIT) is a leading provider of high-performance memory solutions for the networking, telecommunications and military markets and is the developer of the Gemini(R) associative processing unit (APU). GSI's resources are currently focused on bringing new products to market that leverage existing core strengths, including radiation-hardened memory products for extreme environments and Gemini, the APU designed to deliver performance advantages for diverse artificial intelligence applications. Founded in 1995, GSI Technology is headquartered in Sunnyvale, California, and has sales offices in the Americas, Europe and Asia. For more information, visit the company's website at

Helius Medical Technologies Inc. (NASDAQ: HSDT) (TSX: HSM)

Helius Medical Technologies Inc. (NASDAQ: HSDT) (TSX: HSM) is a neurotech company in the medical device industry that is focused on neurological wellness. The company's purpose is to develop, license and acquire unique and noninvasive platform technologies that amplify the brain's ability to heal itself. The company's first commercial product is the Portable Neuromodulation Stimulator (PoNS(TM)). For more information, visit the company's website at

Heritage Global Inc. (CSE: HGP) (OTCQB: HGBL)

Heritage Global Inc. (CSE: HGP) (OTCQB: HGBL) is an asset services company specializing in financial and capital assets. The company provides a full suite of services including market making, acquisitions, dispositions, valuations and secured lending. Heritage Global focuses on identifying, valuing, acquiring and monetizing underlying tangible and intangible assets across 28 global sectors. The company acts as an adviser, as well as a principal, acquiring or brokering turnkey manufacturing facilities, surplus industrial machinery and equipment, industrial inventories, accounts receivable portfolios, intellectual property and entire business enterprises. For more information, visit the company's website at

Hoth Therapeutics Inc. (NASDAQ: HOTH)

Hoth Therapeutics Inc. (NASDAQ: HOTH) is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for dermatological disorders. Hoth's pipeline has the potential to improve quality of life for patients suffering from indications including atopic dermatitis, chronic wounds, psoriasis, asthma and acne. Hoth has also recently entered into two different agreements to further the development of two different vaccine prospects to prevent or treat COVID-19. For more information, visit the company's website at


iCAD Inc. (NASDAQ: ICAD) is a global medical technology leader providing innovative cancer detection and therapy solutions. The company works passionately to provide precise, powerful health care solutions expertly engineered to optimize operational efficiency, clinician confidence and patient outcomes. iCAD offers a comprehensive range of computer-aided detection (CAD) and workflow solutions to support rapid and accurate detection of breast and colorectal cancers. The comprehensive iCAD technology platforms include advanced hardware and software designed to support cancer detection and radiation therapy treatments. For more information, visit the company's website at

iClick Interactive Asia Group Ltd. (NASDAQ: ICLK)

iClick Interactive Asia Group Ltd. (NASDAQ: ICLK) is an independent online marketing and enterprise data solutions provider that connects worldwide marketers with audiences in China. Built on cutting-edge technologies, the company's proprietary platform possesses omnichannel marketing capabilities and fulfills various marketing objectives in a data-driven and automated manner, helping both international and domestic marketers reach their target audiences in China. Headquartered in Hong Kong, iClick was established in 2009 and is currently operating in 10 locations worldwide, including Asia and Europe. For more information, visit the company's website at

Iconic Brands Inc. (OTCQB: ICNB)

Iconic Brands Inc. (OTCQB: ICNB) is a lifestyle branding company with the highest expertise in developing, from inception to completion, alcohol beverage products for itself and third parties. Iconic Brands markets and places products into national distribution through long-standing industry relationships. Iconic is a leader in "celebrity branding" of beverages, procuring superior and unique products from around the world and branding its products with internationally recognized celebrities. The Bellissima offerings include Prosecco DOC Brut, Sparkling Rosé Wine and Zero Sugar Sparkling Wine, all made from organic grapes and certified vegan and gluten free. In addition, Iconic develops private-label spirits for domestic and international established chains. For more information, visit the company's website at

iConsumer Corp. (OTC: RWRDP)

iConsumer Corp. (OTC: RWRDP) is the first company to make it possible to shop like a shark. Every customer automatically becomes an investor in iConsumer by shopping at over 2,000 retailers. Instead of points, cash back or miles, iConsumer uses its publicly traded equity as the shoppers' reward. Online shoppers – many of them first-time investors in a public company, let alone a startup – earn an experience and potential upside previously reserved for the wealthy. Retailers like Amazon, Target, Walmart, Gap and more pay iConsumer to bring them shoppers. More shoppers and more revenue make iConsumer stronger, helping to increase iConsumer's market value. Shoppers directly share in the market value they're creating. For more information, visit the company's website at

Ideal Power Inc. (NASDAQ: IPWR)

Ideal Power Inc. (NASDAQ: IPWR) is pioneering the development of its broadly patented bi-directional power switches, creating highly efficient and eco-friendly energy control solutions for industrial, alternative energy, military and automotive applications. The company is focused on its patented bi-directional, bi-polar junction transistor (B-TRAN(TM)) semiconductor technology. B-TRAN is a unique double-sided bi-directional AC switch that's able to deliver substantial performance improvements over today's conventional power semiconductors. Ideal Power believes B-TRAN modules will reduce conduction and switching losses, complexity of thermal management and operating cost in medium-voltage AC power switching and control circuitry. For more information, visit the company's website at

IDEAYA Biosciences Inc. (NASDAQ: IDYA)

IDEAYA Biosciences Inc. (NASDAQ: IDYA) is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. IDEAYA's approach integrates capabilities in identifying and validating translational biomarkers with small molecule drug discovery to select patient populations most likely to benefit from the targeted therapies IDEAYA is developing. IDEAYA is applying these capabilities across multiple classes of precision medicine, including synthetic lethality – which represents an emerging class of precision medicine targets. For more information, visit the company's website at

IEC Electronics Corp. (NASDAQ: IEC)

IEC Electronics Corp. (NASDAQ: IEC) is a provider of electronic manufacturing services ("EMS") to advanced technology companies that produce lifesaving and mission-critical products for the medical, industrial, aerospace and defense sectors. The company specializes in delivering technical solutions for the custom manufacture of complex full system assemblies by providing on-site analytical testing laboratories, custom design and test engineering services combined with a broad array of manufacturing services encompassing electronics, interconnect solutions and precision metalworking. As a full-service EMS provider, IEC holds all appropriate certifications for the market sectors it supports, including ISO 9001:2015, AS9100D and ISO 13485, and the company is Nadcap accredited. IEC Electronics is headquartered in Newark, New York, and also has operations in Rochester, New York, and Albuquerque, New Mexico. For more information, visit the company's website at

IMAC Holdings Inc. (NASDAQ: IMAC)

IMAC Holdings Inc. (NASDAQ: IMAC) was created in March 2015 to expand on the footprint of the original IMAC Regeneration Center, which opened in Kentucky in August 2000. IMAC Regeneration Centers combine life science advancements with traditional medical care for movement-restricting diseases and conditions. IMAC owns or manages 16 outpatient clinics that provide regenerative, orthopedic and minimally invasive procedures and therapies. It has partnered with several active and former professional athletes, opening six Ozzie Smith IMAC Regeneration Centers, two David Price IMAC Regeneration Centers, multiple Mike Ditka IMAC Regeneration Centers and a Tony Delk IMAC Regeneration Center. IMAC's outpatient medical clinics emphasize its focus around treating sports and orthopedic injuries and movement-restricting diseases without surgery or opioids. For more information, visit the company's website at

Immunovia AB (OTC: IMMVF)

Immunovia AB (OTC: IMMVF) is a diagnostic company that is developing and commercializing highly accurate blood tests for the early detection of cancer and autoimmune diseases based on Immunovia's proprietary test platform called IMMray(TM), an antibody-based multiplex test that is designed to provide a snapshot of the immune system response based on the information available in a single drop of blood. IMMray is more than a technology; it is a systematic approach, based on cutting-edge bioinformatics, to finding the most clinically relevant changes that appear in the blood and combining this knowledge into a 'disease fingerprint' – also called a biomarker signature – that is highly specific to the particular disease. For more information, visit the company's website at


IMV Inc. (NASDAQ: IMV) (TSX: IMV) is a clinical-stage biopharmaceutical company dedicated to making immunotherapy more effective, more broadly applicable and more widely available to people facing cancer and other serious diseases. IMV is pioneering a new class of cancer-targeted immunotherapies and vaccines based on the company's proprietary drug delivery platform. This patented technology leverages a novel mechanism of action that enables the programming of immune cells in vivo, which are aimed at generating powerful new synthetic therapeutic capabilities. IMV's lead candidate, DPX-Survivac, is a T-cell-activating immunotherapy that combines the utility of the platform with a target: survivin. IMV is currently assessing DPX-Survivac as a monotherapy in advanced ovarian cancer, as well as a combination therapy in multiple clinical studies with Merck. IMV is also developing a DPX-based vaccine to fight against COVID-19. For more information, visit the company's website at

Indonesia Energy Corp. Ltd. (NYSE American: INDO)

Indonesia Energy Corp. Ltd. (NYSE American: INDO) is a publicly traded energy company engaged in the acquisition and development of strategic energy projects in Indonesia. IEC's principal assets are its Kruh Block (63,000 acres) located onshore on the Island of Sumatra in Indonesia and its Citarum Block (1 million acres) located onshore on the Island of Java in Indonesia. IEC is headquartered in Jakarta, Indonesia, and has a representative office in Danville, California. For more information, visit the company's website at

InfuSystems Holdings Inc. (NYSE American: INFU)

InfuSystems Holdings Inc. (NYSE American: INFU) is a leading provider of infusion pumps and related durable medical equipment support services to hospitals, clinics and other alternate site health care providers. InfuSystem provides pole-mounted and ambulatory pumps and supplies, along with related clinical, biomedical and billing services, to practices and patients nationwide. Headquartered in Rochester Hills, Michigan, the company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Massachusetts and Ontario, Canada. For more information, visit the company's website at

Inpixon (NASDAQ: INPX)

Inpixon (NASDAQ: INPX) is the Indoor Intelligence(TM) company that specializes in capturing, interpreting and giving context to indoor data so it can be translated into actionable intelligence. The company's Indoor Intelligence platform ingests diverse data from IoT, third-party and proprietary sensors designed to detect and position active cellular, Wi-Fi, UWB and Bluetooth devices. Paired with a high-performance data analytics engine, patented algorithms and advanced mapping technology, Inpixon's solutions are leveraged by a multitude of industries to do good with indoor data. This multidisciplinary depiction of indoor data enables users to increase revenue, decrease costs and enhance safety. Inpixon customers can boldly take advantage of location awareness, analytics, sensor fusion and the internet of things (IoT) to uncover the untold stories of the indoors. For more information, visit the company's website at

Intellicheck Inc. (NASDAQ: IDN)

Intellicheck Inc. (NASDAQ: IDN) is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The company makes it possible for its clients to increase revenues, improve customer service and increase operational efficiencies. The company is focused on partnering with banks, credit card issuers and retailers to prevent fraud. Intellicheck also serves law enforcement agencies, national defense clients and diverse state and federal government agencies. For more information, visit the company's website at

inTEST Corp. (NYSE American: INTT)

inTEST Corp. (NYSE American: INTT) is a global supplier of precision-engineered solutions for use in manufacturing and testing across a wide range of markets, including automotive, defense/aerospace, energy, industrial, semiconductor and telecommunications. Backed by decades of engineering expertise and a culture of operational excellence, the company solves difficult thermal, mechanical and electronic challenges for customers worldwide while generating strong cash flow and profits. inTEST Corp.'s strategy uses these strengths to grow and increase stockholder value by maximizing its businesses and by identifying, acquiring and optimizing complementary businesses. For more information, visit the company's website at

Inuvo Inc. (NYSE American: INUV)

Inuvo Inc. (NYSE American: INUV) is a market leader in artificial intelligence, aligning and delivering consumer-oriented product and brand messaging strategies online based on powerful, anonymous and proprietary consumer intent data for agencies, advertisers and partners. Inuvo AI solutions align brand messaging with appropriate content and consumer intent. The company's unique and patented AI technologies and partnerships enable a sophisticated mix of marketing and e-commerce solutions that are tightly aligned and calibrated to enhance the user experience and create maximum performance for digital commerce companies. For more information, visit the company's website at

Issuer Direct Corp. (NYSE American: ISDR)

Issuer Direct Corp. (NYSE American: ISDR) is an industry-leading communications and compliance company. It primarily focuses on the needs of corporate issuers. Issuer Direct's principal platform, Platform id. (TM), empowers users by thoughtfully integrating the most relevant tools, technologies and services, thus eliminating the complexity associated with producing and distributing financial and business communications. It provides disclosure management solutions, shareholder communications tools and cloud-based compliance technologies. The company serves a diverse range of client bases in the financial services industry, including brokerage firms, banks, mutual funds, accounting agencies and the legal communities. Headquartered in Raleigh, North Carolina, Issuer Direct serves thousands of public and private companies globally. For more information, visit the company's website at

Let's get started.

Interested in a live, online demonstration? Schedule a date and time that works for you.

Schedule a LIVE Demo

Questions about IBN and our solutions? Call or send us an email.

(310) 299-1717